15th Oct 2026 07:00
SkinBioTherapeutics plc ("SkinBioTherapeutics" or the "Group")
Change of Registered Office Address
15 October 2026 - SkinBioTherapeutics plc, (AIM: SBTX), the life science business focused on skin health, announces that its registered office address will change with effect from 16 October 2026 to Unit 75, Windmill Works, Warfield Road, Kelleythorpe Industrial Estate, Driffield, East Yorkshire YO25 9FQ.
The change follows a review of the Company's office requirements ahead of the renewal of its existing lease at The Core in Newcastle. With the Company's UK-based team now operating across a wider geographical area, the Board has taken the opportunity to reassess its office requirements to better reflect the evolving needs of the business and has decided not to renew the lease.
The decision is consistent with the Company's ongoing commitment to maintaining a disciplined approach to its cost base and ensuring that its operational structure remains efficient and appropriate for the business.
-Ends-
For more information please contact:
SkinBioTherapeutics plc Alyson Levett, ChairRachel Parsonage, CEO |
|
Singer Capital Markets (Nominated Adviser & Broker)Alex BondSara HalePatrick Weaver | +44 (0) 020 7496 3000
|
Vigo Consulting Melanie Toyne-SewellRozi Morris | +44 (0) 20 7390 0230 [email protected] |
|
|
Notes to Editors
About SkinBioTherapeutics plc
SkinBioTherapeutics is a life sciences company focused on skin health. The Group's proprietary platform technology, SkinBiotix®, is based upon discoveries made by the translational dermatology team at the University of Manchester.
The Company's strategic approach to skin health is via two routes - tackling skin issues from the 'outside in' and the 'inside out'. The 'outside in' approach is represented by topical creams, and from the 'inside out', via oral supplement solutions which impact the skin via different axes such as the gut and the brain.
SkinBio's products and services are developed through evidence-based science and commercially focused innovation with the aim of supporting skin health, well-being, repair and beauty. SkinBio also has a contract manufacturing and distribution arm related to skin health and other healthcare products.
The Company listed on AIM in April 2017 and is based in Newcastle, UK. For more information, visit: www.SkinBioTherapeutics.com.
Related Shares:
Skinbiotherap.